arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BECTON DICKINSON & CO

BDX
$176.88 ▼ -0.26 (-0.15%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
20 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

BECTON DICKINSON & CO shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $50.9B
Dividend Yield 2.35%
Revenue Growth 8.2%
Op. Margin 11.8%
ROIC 5.3%
FCF / Share None
Trailing P/E 30.3x
Price / Book 2.0x
FCF Yield
Debt / Equity 0.69
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$21.84B
↑ +8.2%
Net Income Profit after all expenses
$1.68B
↓ -1.6%
Operating Margin Operating profit as % of sales
11.8%
↓ -0.6% 60th
FCF / Share Free cash flow per share
$11.81
↑ +20.7%
Long-Term Debt Long-term obligations
$17.62B
↓ -1.8%

Health Breakdown

Profitability
60
Returns
58
Financial Health
55

Dividend History

Dividend / share · sourced from SEC filings
$4.16 Latest / share
+9.5% YoY
+6.1% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters